Hypofibrinolysis Associated with Vasculopathy in Non Insulin Dependent Diabetes Mellitus

Overview

Journal Thromb Res

Date 1990 Jul 1

PMID 2119076

Citations 10

Authors

L J Garcia Frade

H de la Calle

M C Torrado

J I Lara

L Cuellar

A Garcia Avello

Affiliations

Soon will be listed here.

Abstract

The pathogenesis of diabetic vasculopathy has been related to modifications in hemostasis and fibrinolysis. 50 non insulin dependent diabetes mellitus patients have been studied. Euglobulin clot lysis time, fibrin plate, tissue plasminogen activator (t-PA) antigen, plasminogen activator inhibitor (PAI) activity, Protein C and S, cholesterol, triglycerides and Hb A1c were determined in blood samples. Diabetic patients showed decreased fibrinolytic activity, as measured by ECLT, with clearly increased PAI levels. Fibrinolytic response to venous occlusion was lower than normal. Vascular complications were associated both with an even higher PAI activity and with a decreased fibrinolytic response to venous occlusion. Elevated PAI activity and decreased fibrinolytic response to stimulus may contribute to vascular disease in diabetes.

Citing Articles

Detection of early allograft dysfunction at 30 min of reperfusion in liver transplantation: An intraoperative diagnostic tool with real time assessment of graft function.

Moore H, Yaffe H, Pomposelli J, Wachs M, Bak T, Kennealey P Am J Surg. 2020; 220(6):1518-1525.

PMID: 32907708 PMC: 7722050. DOI: 10.1016/j.amjsurg.2020.08.018.

Fibrinolysis Shutdown in Trauma: Historical Review and Clinical Implications.

Moore H, Moore E, Neal M, Sheppard F, Kornblith L, Draxler D Anesth Analg. 2019; 129(3):762-773.

PMID: 31425218 PMC: 7340109. DOI: 10.1213/ANE.0000000000004234.

Altered Daytime Fluctuation Pattern of Plasminogen Activator Inhibitor 1 in Type 2 Diabetes Patients with Coronary Artery Disease: A Strong Association with Persistently Elevated Plasma Insulin, Increased Insulin Resistance, and Abdominal Obesity.

Lalic K, Jotic A, Rajkovic N, Singh S, Stosic L, Popovic L Int J Endocrinol. 2015; 2015:390185.

PMID: 26089884 PMC: 4451778. DOI: 10.1155/2015/390185.

Administration of glutathione in patients with type 2 diabetes mellitus increases the platelet constitutive nitric oxide synthase activity and reduces PAI-1.

Martina V, Bruno G, Zumpano E, Origlia C, Quaranta L, Pescarmona G J Endocrinol Invest. 2001; 24(1):37-41.

PMID: 11227730 DOI: 10.1007/BF03343806.

Coagulation pathways and diabetic retinopathy: abnormal modulation in a selected group of insulin dependent diabetic patients.

Giusti C, Schiaffini R, Brufani C, Pantaleo A, Vingolo E, Gargiulo P Br J Ophthalmol. 2000; 84(6):591-5.

PMID: 10837382 PMC: 1723519. DOI: 10.1136/bjo.84.6.591.